STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories
“These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease."
Reported by STAT. We will add other newspapers as they cover it.
How the newspaper covers this story
STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories
“These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease."
· STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy
· STAT+: Why the latest heart drug failures should make us all more skeptical of AI hype
